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Abstract
Several studies have suggested that free D-Asp has a crucial role in N-methyl D-Asp recep-
tor-mediated neurotransmission playing very important functions in physiological and patho-
logical processes. This paper describes the development of an analytical procedure for the
direct and simultaneous determination of free D-Asp, L-Asp and N-methyl D-Asp in speci-
mens of different mouse brain tissues using chiral LC-MS/MS in Multiple Reaction Monitor-
ing scan mode. After comparing three procedures and different buffers and extraction
solvents, a simple preparation procedure was selected the analytes of extraction. The
method was validated by analyzing L-Asp, D-Asp and N-methyl D-Asp recovery at different
spiked concentrations (50, 100 and 200 pg/μl) yielding satisfactory recoveries (75–110%),
and good repeatability. Limits of detection (LOD) resulted to be 0.52 pg/μl for D-Asp, 0.46
pg/μl for L-Asp and 0.54 pg/μl for NMDA, respectively. Limits of quantification (LOQ) were
1.57 pg/μl for D-Asp, 1.41 pg/μl for L-Asp and 1.64 pg/μl for NMDA, respectively. Different
concentration levels were used for constructing the calibration curves which showed good
linearity. The validated method was then successfully applied to the simultaneous detection
of D-Asp, L-Asp and NMDA in mouse brain tissues. The concurrent, sensitive, fast, and
reproducible measurement of these metabolites in brain tissues will be useful to correlate
the amount of free D-Asp with relevant neurological processes, making the LC-MS/MS MRM
method well suited, not only for research work but also for clinical analyses.
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Introduction
Although the L-enantiomer forms of amino acids greatly predominate in nature, D-enantio-
mers generated from the post-translational isomerization modifications on L-amino acids have
been detected in bacteria, plants, in different phyla of invertebrates as well as in vertebrate ani-
mals up to mammals, including humans [1–5]. Their appeal derives from the multiplicity of
performed physiological functions, some of them not yet elucidated. D-Ala, D-Glu, D-Asn are
components of bacteria cell wall peptidoglycans and in the same organisms D-Phe, D-Tyr, D-
Met and D-Leu appeared to modulate peptidoglycans synthesis displaying a regulatory mecha-
nism of cellular growth [6]. The slight structural changes due to the chirality inversion seem to
be responsible for the bioactivity of D-amino acid containing peptides as it occurs for dermor-
phin where D-Ala displays selectivity and high affinity for human μ-type opiate receptors [7].
Among all the D-amino acids, D-Ser and D-Asp are the amino acids more investigated for their
crucial role especially in mammalian tissues [8–9]. Indeed, the concentration of D-Asp follows
a peculiar temporal pattern of emergence in endocrine glands, with its increase in the postnatal
and adult phase following the functional maturation of these organs [10]. Conversely, in the
brain, the strong decrease of free D-Asp levels after birth is a consequence of the postnatal
onset of D-aspartate oxidase (DDO), the only known enzyme that catabolizes D-Asp [11]. In
this organ, D-Asp appeared particularly concentrated in the synaptic vesicles of terminal axon,
suggesting its role as an endogenous neurotransmitter [10, 12]. D-Asp enhances hippocampal
N-Methyl D-Asp receptor (NMDAR)-dependent synaptic plasticity, dendritic morphology,
spatial memory and learning processes [13]. A significant reduction of D-Asp levels has been
also recently found in the prefrontal cortex of patients with schizophrenia, associated with an
increased expression of DDO mRNA [14].
Due to its physiological relevance, a number of different methods have been proposed to
detect D-Asp, including gas chromatography, high-performance liquid chromatography
(HPLC), high-performance capillary electrophoresis (CE) and enzymatic procedures [15–16].
Besides the enantioseparation, the analysis of D-Asp in biological samples is challenging
because of the large amount of its L-counterpart and the presence of several biological sub-
stances interfering with the analysis. However, the crucial issue correlated to this analysis
remains the enantioseparation of D-Asp from L-Asp, due to their similar chemical and physical
properties, excluding configuration.
Many papers describe protocols including a preliminary step of derivatisation with a fluoro-
genic chiral reagent [17] or with fluorogenic non-chiral reagents providing a separation on
single chiral stationary phase [18] or on two subsequent chromatographic steps linked by an
automated column-switching device [19–24]. Other methods provide the conversion of each
enantiomer into octyl ester derivatives for the direct gas chromatography-mass spectrometry
(GC-MS) analysis, as described for the determination of N-methyl-DL-aspartic acid (NMA)
[25]. However, most of enantionseparation protocols are based on coupling of liquid chroma-
tography to mass spectrometry as that combining Chirobiotic T chiral stationary phase
column to atmospheric pressure chemical ionization (APCI) mass spectrometry for the
quantification of 25 amino acid enantiomers [26]. Others are focused on the optimization of
performing MS analysis e.g. by exploiting the different level of vibrational excitation of enan-
tiomers in two different dissociation modes [27], or on chiral separation by ion mobility spec-
trometry [28].
Targeted metabolomics making use of LC-MS/MS in Multiple Reaction Monitoring
(MRM) scan mode was shown to be effective in identifying altered metabolic pathways in
pathological conditions and/or to define therapeutic modes of action [29]. In this context,
recently Livnat and co-workers successfully separated all the twenty L-amino acids from their
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isomers on Phenyl-Hexyl column and quantified them in a single MRM run [4]. However, this
protocol suffered of longer preliminary steps of derivatisation of the L- and D-amino acids
with the Marfey’s reagent.
The present paper describes the development of a simple and reliable procedure for the
extraction and the simultaneous direct determination of free L-Asp, D-Asp, and its derivative
NMDA in specimens of mouse brain tissues by coupling chiral liquid chromatography to tan-
dem mass spectrometry in MRM scan mode. Given the crucial role of DDO enzyme in the
regulation of D-Asp physiological levels, the above mentioned metabolites were successful
extracted by brain tissues from wild-type (DDO+/+) and knockout (DDO-/-) mice, separated by
HPLC Astec Chirobiotic chiral phase column and quantified by single run LC-MS/MS-MRM
analysis without any derivatisation step. This preliminary study is addressed at the specific,
sensitive, fast and reproducible measurement of this metabolites in brain tissues in order to
correlate the amount of D-Asp with relevant neurodegenerative processes and to monitor the
effect of specific therapeutic treatments.
Finally, the developed method has the great potentiality to be extended to a wide number of
molecules, including all the existing D-amino acids, and the possibility to simultaneously mon-
itor them in a single run, by optimization of the MRM parameters. This approach could open
new insights into the clinical diagnostics of neuropathological diseases.
Materials and methods
Chemicals and reagents
N-methyl D-Asp (NMDA), D-Asp, L-Asp, were purchased from Sigma-Aldrich. All solutions
and solvents of the highest available purity and suitable for LC-MS analysis were purchased
from J. T. Baker (Phillipsburg, NJ). All stock solutions were stored at −20˚C.
All research involving animals was performed in accordance with the European directive
86/609/EEC governing animal welfare and protection, and was approved by the Animal Wel-
fare and Ethical Review Body Committee (AWERBC) of Ceinge Biotecnologie Avanzate in the
light of the project no GR-2009-1605759 approved by the Italian Ministry of Health.
Knockout mice for the DDO gene were generated and genotyped by PCR as described
previously [30]. Wild-type (DDO+/+) and knockout (DDO-/-) mice were housed in groups
(n = 4–5) in standard cages (29 x 17.5 x 12.5 cm) at constant temperature (22 ± 1˚C) and main-
tained on a 12/12 h light/dark cycle, with food and water ad libitum. All efforts were made to
minimize the animal suffering. Mice were killed by decapitation and the prefrontal cortex dis-
sected out within 20 s on an ice-cold surface and then stored at -80˚C for subsequent analyses.
Preparation of standard solutions
Stock solutions were prepared by adding 1.0 mL aliquots of each analyte to a 10-mL volumetric
flask and bringing the standard to volume with methanol to yield a standard solution with
1000 ng/mL of each analyte. Stock solutions were stored at −20˚C until the analysis.
Individual standard solution
Final 2000 pg/μl individual analyte standard solutions were prepared by serial dilution from
stock solutions and used for calibration curves. Standard mixtures for each analyte were pre-
pared at the following concentrations: 0.5, 1, 25, 50, 125, 200, 300 pg/μl for D-Asp; 1, 5, 25, 50,
125 pg/μl for L-Asp; 0.25, 0.5, 2.5, 5, 10, 25, 50 for NMDA. All standards were kept at -20˚C
before LC-MS/MS analysis.
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Sample preparation
Aliquots of 0.5 g of mouse brain tissues were homogenized using different buffers including
ammonium bicarbonate 10 mM pH7.5, ammonium bicarbonate 50 mM pH 8.0, Tris-HCl 50
mM pH 8.0, Hepes 50mM pH 8.0. Samples were added with 100 pg/μl of standard analytes to
quantitatively evaluate the best conditions of sample preparation. Samples were then sonicated
for different times (from 10 to 120 min with 10 min increments) until a clear solution was
obtained. Each test sample was then divided in three aliquots and the analytes extracted in the
supernatant by precipitation of the protein components using different solvent systems (aceto-
nitrile, ethanol, methanol). An aliquot of 0.6 ml of organic solvent was added to each sample
and the tube was mechanically shaken vigorously for 5 min. The tube was centrifuged at 10000
rpm (7600 rcf) at 10˚C for 10 min. Using a Pasteur pipette, the upper organic layer was trans-
ferred into a centrifuge tube. 0.2 ml of upper organic layer was filtered through a 0.2-μm PTFE
syringe filter (Pall Acrodisc 13 mm) into an LC vial for analysis.
Once defined the best conditions for sample preparation, control samples were fortified in
triplicate at three different target levels (50, 100 and 200 pg/μl) by adding the standard solution
containing the same concentration of the three analytes to 200 μl of homogenized control tis-
sues (0.5 g) for validation of the method.
LC–MS/MS instrumentation and conditions
The supernatant (2 μl) were analysed by using an Agilent 6420 Triple Quadrupole LC-MS/MS
system with a HPLC 1100 series binary pump (Agilent, Waldbronn, Germany).
A mixture of D-Asp, L-Asp and NMDA (100 pg/μl each) was resolved on a HPLC Astec
Chirobiotic chiral phase column (10 cm x 4.6mm, 5μm), consisting of the amphoteric glyco-
peptide Teicoplanin covalently bound to a 5 μm spherical silica gel through multiple covalent
linkages. The mobile phase was generated by mixing eluent A (0.1% Formic Acid in 2% ACN)
and eluent B (0.009% Formic Acid in methanol) and the flow rate was 0.5 mL/min. Elution
gradient was from 50% to 95% B in 6 min.
Tandem mass spectrometry was performed using a turbo ion spray source operated in posi-
tive mode, and the MRM mode was used for the selected analytes. A standard solution of 500
pg/μl of each metabolite was used for optimization of the MRM transition as reported in
Table 1. Metabolites were automatically (flow injection) tuned for ionization polarity, optimal
declustering potential (DP), product ion, and collision energy (CE) using metabolite standard
solutions via Agilent MassHunter Optimizer software. Table 1 provides a list of precursor ion,
product ions, collision energy and retention times for all analytes.
Table 1. Mass spectral parameters and retention times for the L-Asp, D-Asp and NMDA analytes. The most intense transitions for each analyte,
134.0>116.0 for L-Asp and D-Asp and 148.0>88.0 for NMDA were used for the quantification while the others were used for the identification.
Compound
Name
Precursor Ion
(m/z)
Product Ion
(m/z)
Dwell
(ms)
Abundance
(counts)
Fragmentor
(V)
Collision
Energy (V)
Cell Accelerator
Voltage (V)
Polarity RT
(min)
L-Asp 134.0 116.0 200 15478 81 1 7 Positive 3.38
134.0 88.0 200 12365 81 8 7 Positive
134.0 74.0 200 10115 81 9 7 Positive
D-Asp 134.0 116.0 200 13254 81 1 7 Positive 3.73
134.0 88.0 200 12356 81 8 7 Positive
134.0 74.0 200 10365 81 9 7 Positive
NMDA 148.0 130.0 200 874 81 1 7 Positive 4.4
148.0 88.0 200 16485 81 9 7 Positive
148.0 42.0 200 12474 81 25 7 Positive
https://doi.org/10.1371/journal.pone.0179748.t001
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Data processing
Extracted mass chromatogram peaks of metabolites were integrated using Agilent MassHunter
Quantitative Analysis software (B.05.00). Peak areas of corresponding metabolites are then used
as quantitative measurements for assay performance assessments such as variation, linearity etc.
Method validation
Limit of detection and quantitation. The limits of detection (LODs) were defined as the
lower limit of concentration below which the sample could not be revealed and were deter-
mined by making 10 replicate measurements of blank samples spiked with low concentrations
of each analyte. Calculations were made according to the following formula: LOD = 3 times
standard deviation (SD).
The limit of quantitation (LOQ) is the lowest concentration at which the analyte can not
only be reliably detected but also quantitated. The LOQ may be equivalent to the LOD or
higher. Standard solutions were prepared by spiking known amount of D-Asp, L-Asp and
NMDA in the control mouse brain sample. The metabolites were extracted and analysed by
the LC-MS/MS procedure. LOQ was determined as the analyte concentration giving a signal
to noise ratio (S/N) of 10.
Matrix effect. Possible matrix effects were evaluated by comparing standard and matrix-
matched calibration curves for each analyte. Standard solutions were prepared as described.
Wild type tissue samples treated with DDO were extracted as described and spiked with the
target compounds, resulting in matrix-matched solutions. The calibration curves were
repeated three times. Matrix effects were evaluated by comparing five points standard and
matrix-matched calibration curves.
Specificity. The specificity of the assay was demonstrated by checking for interfering
peaks at the retention time of the target analytes.
Stability. The stability of the analytes in matrices was determined on short-term condi-
tions (−20˚C, 7 days). All sample stability studies were evaluated by comparing the area of the
analytes in freshly prepared matrices with that of storage matrices and performed in triplicate.
When the area of the analytes in storage matrices was lower than 10% compared to the area of
the analytes in freshly prepared matrices, the analytes in matrices were considered not stable.
Selectivity. Selectivity was evaluated by analyzing 20 blank samples. The blank samples
were prepared by executing the whole analysis procedure without test sample and omitting the
standards addition.
Selectivity was defined acceptable when no peaks were detected in the chromatogram of the
procedural blank sample at the retention time of the analytes ± 0.1 minute or, if present, peaks
did not exceed 30% of the height of the native analyte in the chromatogram of the lowest cali-
bration level.
Linearity. The linearity of an analytical procedure is defined as its ability to obtain test
results that are directly proportional to the concentration (amount) of analyte in the sample
within a given range. Linearity was demonstrated directly on the standard solutions by dilu-
tion of a standard stock solution as described. Linearity was determined by a series of three
injections of standards at different concentration levels. A linear regression equation was
applied to the results. The linearity is evaluated graphically, by calibration curves, and by visu-
ally inspecting a plot of peak area as a function of analyte concentration
Precision (repeatability and intermediate precision). Precision was assessed at the low-
est limit of the working range level from matrix samples, which were spiked with a known
amount of standard solutions Triplicate analyses on three different days were performed on
each spiked sample.
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Repeatability and intermediate precision estimates were calculated by ANOVA and
expressed as relative standard deviation. The obtained repeatability relative standard devia-
tions (RSDr) were calculated. Intermediate precision was evaluated from triplicate analysis in
three independent analysis sequences performed over a period of one month.
Recovery. Recovery values were calculated from the measurement of standards spiked in
test samples. The average recoveries and their relative standard deviations were calculated
from all the results obtained for each standard via response factors, which were determined
from calibration solutions as follows:
Recoveryð%Þ ¼
c1   c2
c3
 100
where:
C1: analyte concentration measured after the addition
C2: analyte concentration measured before the addition
C3: added concentration
Recovery values were not used for correction of analysis results. They were only used to
monitor the yield of the sample preparation procedures.
Measurement uncertainty. Measurement uncertainty was estimated according to the law
of error propagation. The uncertainty contributions considered in the combined uncertainty
were the uncertainties of the preparation of native standard solutions for instrument calibra-
tion, the uncertainty of the preparation of spiking solutions for the preparation of test samples,
the uncertainty contribution deriving from instrument calibration, the uncertainty coming
from the precision of the analyses and the uncertainty of bias.
Results
Preliminary analyses were carried out for optimizing the HPLC separation and LC-MS/MS
conditions by using L-Asp, D-Asp and NMDA as a standard metabolite solution. Several
extraction procedures were also assessed and a validation process was followed for testing the
matrix effect. LOD and LOQ, the precision and accuracy, the recovery in matrix before pro-
ceeding with the determination of D-Asp, L-Asp and NMDA in mouse brain tissues were also
evaluated.
Enantiomeric separation
The specific separation of the three analytes was obtained by using a Teicoplanin column con-
taining 23 chiral centers surrounding four pockets or cavities with hydrogen donor and accep-
tor sites readily available [19]. This type of arrangement is known to be highly favourable for a
number of enantiomeric separations. Elution of the enantiomers was accomplished by an
unbuffered mixture of methanol and acetonitrile containing a small amount of formic acid
providing an optimal coupling with the following mass spectral analysis. Fig 1 shows the total
ion current (TIC) chromatogram obtained for the analysis of 100 pg/μl standard mixture solu-
tion showing a good peak shape for the three analytes. Several injections of the standard mix-
ture were carried out to ensure reproducibility of retention times.
Mass spectral parameters selection
Next step consisted in the selection of the best mass spectral parameters for the MRM detec-
tion of the analytes. D-Asp, L-Asp and NMDA were individually infused to establish the opti-
mal instrument settings for each compound. Experimental automatic tuning by using
MassHunter Optimizer was used to define ionization polarity, to select the best product ion
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(Q3 ion) and to optimize both the collision energy (CE) and the declustering potential (DP).
The MRM transitions and all the instrumental parameters determined are summarised in
Table 1. It should be underlined that the NMDA transitions were specific for this metabolite
and different from its isomer Glu (148! 130; 148! 102; 148! 84). The MRM chromato-
grams obtained for standard solutions of D-Asp, L-Asp and NMDA showing a good selectivity
for all analytes, with all transitions correctly occurring at the same retention time are reported
in S1 Fig.
Sample extraction procedure
First, a reliable sample extraction procedure had to be optimised keeping sample manipulation
to a minimum because of the low concentration of D-Asp occurring in most biological sam-
ples. Target analytes were extracted from freeze-dried specimens of mouse brain tissues follow-
ing a two-steps procedure consisting in sonication of the sample and protein precipitation
prior to LC-MS/MS analysis. Different buffers and sonication parameters were evaluated as
reported below.
Each test sample was then divided in three aliquots and the analytes extracted in the super-
natant by precipitation of the protein components using different solvent systems (acetonitrile,
ethanol, methanol). All test samples were then analysed by the LC-MS/MS MRM procedure to
Fig 1. Total ion current (TIC) chromatogram for the analysis of 100 pg/μl standard mixture solution of L-Asp, D-Asp and NMDA.
Peaks corresponding to each analyte are labelled.
https://doi.org/10.1371/journal.pone.0179748.g001
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evaluate the best conditions for sample preparation. As an example, Fig 2 shows the LC-MS/
MS analyses in MRM mode of test samples from mouse brain tissues prepared in three differ-
ent conditions. The recovery of analytes in the different conditions explored is reported in S1
Table. According to the data shown in S1 Table, the best results were obtained by dissolving
the mouse brain samples in Tris-HCl 50 mM pH 8.0 followed by sonication for 10 min and
using methanol for protein precipitation. Extending the precipitation time beyond 30 min
(i.e., up to 2 hours) did not increase the analyte recovery. Experiments were performed in trip-
licate for each pair of conditions and averaged.
Possible mass spectral interferences from biological specimens were then investigated. A
control matrix only containing L-Asp was prepared by using a sample of adult mouse brain
treated with DDO in order to completely remove endogenous D-Asp and NMDA [30]. The
Fig 2. LCMSMS analyses in MRM mode of test samples from mouse brain tissues to optimise the sample
treatment procedure. Some experimental conditions for sample extraction and precipitation are reported in the
figure. Peaks corresponding to each analyte are labelled.
https://doi.org/10.1371/journal.pone.0179748.g002
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absence of any amount of free D-Asp in the sample used as control matrix was verified by
LC-MS/MS analysis using the MRM method containing the transitions selected for the three
analytes. As expected, Fig 3 shows the corresponding MRM chromatogram only displaying the
L-Asp peak. No transitions for D-Asp and NMDA were detected demonstrating the absence of
these metabolites in the control matrix.
Method validation
Linearity and matrix effect were studied using standard solutions and matrix matched calibra-
tions. Matrix matched calibration curves were prepared by spiking extracts from control tis-
sues with known amounts of L-Asp, D-Asp and NMDA. Both standard and matrix matched
calibration curves were constructed by plotting peak areas against concentration (pg/μl) and
linear functions were applied to the calibration curves. Data were integrated by Mass Hunter
quantitative software showing a linear trend in the calibration range for all molecules. The
coefficients of determination (R2) were greater than 0.99 for all analytes. The signal corre-
sponding to L-Asp was corrected for the presence of the endogenous metabolite in the control
matrix. Fig 4 shows the standard calibration curves obtained for the three analytes.
The matrix effect was calculated as the percentage of the matrix matched calibration slope
(B) divided by the standard calibration slope (A) yielding a matrix effect (B/A x 100) of 11–
15% for the three analytes.
The limits of detection (LODs) were determined by making 10 replicate measurements of
blank samples spiked with low concentrations of each analyte and calculated as: LOD = 3  SD.
The LODs of D-Asp, L-Asp and NMDA resulted to be 0.52 pg/μl for D-Asp, 0.46 pg/μl L-Asp
and 0.54 pg/μl for NMDA, respectively.
The precision and accuracy at different concentration levels were calculated for each analyte
and resulted to be in the range of %RSD = 1.0–9.0 with the recovery efficiency (%RE) being in
the range 9.6–10.3, well suited for the quantitative measurement of these metabolites in brain
tissues. Data were collected over a period of 10 days and each measurement represents the
average of three experiments. Table 2 reports the determined parameters for L-Asp, D-Asp and
NMDA.
Fig 3. MRM chromatogram for a DDO treated matrix sample only displaying the L-Asp component.
The specific MRM transitions for monitoring the L-Asp analyte are indicated.
https://doi.org/10.1371/journal.pone.0179748.g003
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Fig 4. Calibration curves obtained for the three analytes.
https://doi.org/10.1371/journal.pone.0179748.g004
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In order to define the recovery in matrix and the LOQ, standard solutions were then pre-
pared by spiking known amount of D-Asp, L-Asp and NMDA in the control mouse brain sam-
ples. Tissue samples were weighed and sonicated in TrisHCl 50 mM pH 8.0; the analytes were
extracted and analysed by the LC-MS/MS procedure using the conditions previously defined.
The endogenous background of each analyte was corrected in the Mass Hunter software by
calculating the non-spiked signal. LOQ, calculated as the analyte concentration giving a signal
to noise ratio (S/N) of 10, resulted to be 1.57 pg/μl for D-Asp, 1.41 pg/μl for L-Asp and 1.64 pg/
μl for NMDA, respectively. Recovery was calculated by comparing the extraction yield before
and after the addition of the different standard analytes into the control tissue samples. Quan-
titation was achieved by using the calibration curves. Recovery for each analyte was better than
90% (see Table 2).
Table 2. Validation parameters of the analytical method developed for the quantitative determination of L-Asp, D-Asp and NMDA. Each measure-
ment represents the average of three technical replicates.
NMDA
Sample Conc. pg/μl Response Average SD RSD%
1 2 3
0.25 101.4 92.4 108.0 100.6 7.8 7.8
2.5 481.0 433,5 510.6 475.0 38.9 8.2
5 1071.4 999.7 1137.4 1069.5 68.9 6.4
10 2649.2 2390.5 2825.5 2621.7 218.8 8.3
25 5579.2 5085.9 6054.0 5573.2 484.1 8.7
50 12956.4 11717.1 14243.7 12972.4 1263.3 9.7
L-Asp
Sample Conc. pg/μl Response Average SD RSD%
1 2 3
1 300.2 288.4 296.3 295.0 6.0 2.0
5 1500.3 1425.6 1521.4 1482.4 50.3 3.4
25 9900.4 9852.1 9745.0 9832.5 79.5 0.8
50 21900.8 21105.3 22001.3 21669.1 490.8 2.3
125 51478.1 50421.4 51235.1 51044.9 553.5 1.1
D -Asp
Sample Conc. pg/μl Response Average SD RSD%
1 2 3
1 50.7 54.88 45.5 50.3 4.7 9.4
5 82.4 75.60 87.4 81.8 5.9 7.2
25 309.3 323.70 282.1 305.0 21.1 6.9
50 579.3 620.46 625.9 608.6 25.5 4.2
80 823.6 876.54 866.1 855.4 28.0 3.3
125 1440.4 1526.87 1440.4 1469.2 49.9 3.4
Compound LOD (pg/μl) LOQ (pg/μl) Linear range (pg/μl) Matrix effect %
D-Asp 0.52 1.57 1–125 11
L-Asp 0.46 1.41 1–125 14
NMDA 0.54 1.64 0.25–50 15
Compound Linearity (R2) Recovery ± RSD (%)
Standard Matrix 50 pg/μl 100 pg/μl 200 pg/μl
D-Asp 0.998 0.996 73.9±1.1 87.8±9.4 106.8±1.3
L-Asp 0.994 0.992 75.9±1.3 86.1±9.8 108.2±1.1
NMDA 0.994 0.993 74.9±1.5 82.4±9.1 104.1±1.6
https://doi.org/10.1371/journal.pone.0179748.t002
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D-Asp, L-Asp and NMDA determination in mouse brain tissues
The reliability of the developed procedure and its possible application to clinical analyses were
evaluated by determining the concentration of D-Asp, L-Asp and NMDA in several mouse
brain tissues at different times of development. Freeze-dried specimens from mouse brain tis-
sues were sonicated and precipitated according to the simple developed method, avoiding
heavy sample handling. The supernatant from protein precipitation was directly analysed by
tandem mass spectrometry in MRM scan mode. The analytes concentrations were calculated
in pg/μl and then expressed in nmol/g of brain tissue in order to perform a comparison with
data presented in the literature. As an example, Fig 5 shows the TIC and the MRM transitions
recorded for the three molecules in a sample from prefrontal cortex of wild type mouse, indi-
cating that the three metabolites could be easily quantitated.
Finally, the same analysis was performed on prefrontal cortex samples from both wild type
and knockout mice for DDO gene (DDO+/+ and DDO-/-, respectively) [30] (see Table 3). Fig 6
showed the results obtained by the LC-MS/MS procedure demonstrating that in DDO-/- mice
sample the D-Asp levels are much higher compared to DDO+/+ littermates. Moreover, the D-
Asp/L-Asp ratio determined by LC-MS/MS (0.012 for DDO-/- mice and 0.441 for DDO+/+, see
Fig 6) was approximately coincident with those previously obtained by HPLC measurements
[30] (0.019 for DDO-/- mice and 0.624 for DDO+/+, manuscript in preparation).
Fig 5. TIC and MRM chromatograms recorded for the three analytes in a sample from prefrontal
cortex of wild type mouse. The specific MRM transitions for each analyte are indicated.
https://doi.org/10.1371/journal.pone.0179748.g005
Table 3. Quantitative determination of L-Asp, D-Asp and NMDA in samples from mouse prefrontal cor-
tex by MRM LC-MSMS analysis. Samples were obtained from brain of three individual animals from each
group (DDO+/+, wild type mouse; DDO-/-, D-aspartate oxidase (DDO) knockout mouse). Each measurement
represents the average of three technical replicates.
Brain Tissue sample L-ASP nmol/g D-Asp nmol/g NMDA nmol/g
Mouse 1 DDO+/+ 8190±819 113±11 1.2 ±0.1
Mouse 2 DDO-/- 9830±983 5150±515 2.9±0.3
Mouse 3 DDO+/+ 10600±1060 130±13 1.8±0.2
Mouse 4 DDO-/- 9990±990 5330±533 2.3 ±0.2
Mouse 5 DDO+/+ 9340±934 127±13 1.5±0.1
Mouse 6 DDO-/- 9570±957 5230±523 2.4±0.2
https://doi.org/10.1371/journal.pone.0179748.t003
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Discussion
Many in vivo and in vitro studies have suggested that D-Asp has a crucial role in NMDA recep-
tor-mediated neurotransmission playing very important functions in physiological and patho-
logical processes [12–14, 31]. Moreover, a significant reduction of D-Asp was observed in brain
of patients with schizophrenia [13] in line with the hypothesis of a NMDARs hypofunction in
this pathology [31]. These crucial biological functions trigger the need for a simple, reliable
and effective methodology to quantitate the levels of D-Asp and its derivative NMDA in brain
tissues, as the alteration of their amount would be of invaluable clinical and diagnostic value.
As D-Asp occurs at very low concentration in most biological samples, a reliable extraction
procedure with minimum sample handling needed to be also optimised.
Enantio-separation through liquid extraction technology is a well established field in key
research areas such as pharmaceutical industry, food additives and life science [32–33]. Analyt-
ical methods using a chiral stationary-phase column [34] or pre-column derivatisation with a
chiral reagent [35] have been developed for separation and determination of N-methyl-DL-
aspartic acid (NMA) in bivalves, octopus and mollusk tissues. However, the use of derivatising
agents is often not recommended due to the enantiomeric impurities and incomplete reactions
giving false positive results and quantification errors. Moreover, LOD obtained for derivatised
amino acids analysed by different HPLC methods resulted to be at least 10 times higher than
the values obtained by MRM measurements [35–37]. As already demonstrated, the LOD for
acidic amino acid by MS analysis was 100 times lower than that by HPLC-UV method and it
was much lower for other amino acids [26]. The LOD values recorded by our MRM method
resulted to be in perfect agreement, and even lower in some cases, with LODs measured in
other LC-MS/MS analyses of D-amino acids in biological samples [38–41]. Comparable LOD
of a few ppb was achieved also by coupling of fluorescence-based detection to chiral columns
e.g. for D-Asp derivatised with 4-fluoro-7-nitro-2,1,3-benzoxadiazole quantified in rat brain
tissues, plasma, and urine [42]. CE laser induced fluorescence (LIF) detection systems are
increasingly used for the chiral separation of all the amino acids due to the high separation effi-
ciency, and compatibility with sensitive detection methods including MS instruments [43].
Although the LOD by such method achieves concentration of the low nM for several molecules
[44], recent data related to D-Asp quantification showed LOD of 17 nM (2.3 ppb) in chicks
brain tissues [45] and 8 nM (1 ppb) in various brain regions of adult mice [46], 4 and 2 fold,
respectively, higher than LOD recorded with our MRM method. Peak assignments for most of
these methods needed to be confirmed [47].
In this paper, we describe a simple and rapid method for the simultaneous direct measure-
ment of free D-Asp, L-Asp and NMDA in brain tissues based on chiral fractionation of
Fig 6. Quantitative analysis of D-Asp (left panel) and D-Asp versus L-Asp ratio (right panel) in samples
from mouse prefrontal cortex using the developed LC-MS/MS MRM procedure. DDO+/+, wild type
mouse; DDO-/-, D-aspartate oxidase (DDO) knockout mouse.
https://doi.org/10.1371/journal.pone.0179748.g006
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enantiomers and tandem mass spectrometry in MRM mode avoiding any derivatisation step.
The elution of extracted metabolites was accomplished using a mixture of organic solvent that
provided an optimal coupling with mass spectrometry avoiding complex pre-cleaning of the
samples and making the analytical procedure simpler and faster. D- and L-Asp were distin-
guished by their retention time on chiral chromatography and all three compounds could be
unambiguously identified by their specific MRM transitions with LOD of 0.5 ppb. The MRM
method was able to discriminate the target metabolites within the very complex mixture origi-
nated from prefrontal cortex samples of both DDO+/+ and DDO-/-mouse, an animal model in
which the DDO gene has been genetically deleted [30]. These results were comparable with the
same measurements carried out by HPLC [30] and the D-Asp/L-Asp ratio determined by
LC-MS/MS was in very good agreement with that obtained by HPLC. The elevated amount of
D-Asp in the knockout mouse was expected as the absence of DDO in the brain decreases the
oxidation rate of D-Asp leading to an increase in concentration of the free amino acid. This
event is thought to be correlated to schizophrenia. The enantiomer N-Methyl L-Asp (NMLA)
was not included in the analyses as this metabolite is not involved in NMDA-receptor modula-
tion and was demonstrated to be the less potent antagonist of Glu in brain synaptic mem-
branes [48].
In conclusion, the developed method provided to be a reliable and effective procedure for
direct measurements of free D-Asp, L-Asp and NMDA in brain tissues and was successfully
applied as a rapid screening for detection of these metabolites levels in different mouse brain
districts (manuscript in preparation). The relative simplicity of sample preparation together
with its high sensitivity makes the LC-MS/MS MRM method well suited, not only for research
work but also, for the measurement of clinical samples. The methodology we developed allows
simultaneous D-Asp, L-Asp and NMDA profiling in brain but can be easily extended to differ-
ent class of metabolites, and easily expandable to clinical samples screening for the follow-up
of patients and/or to monitor therapeutic treatments.
Supporting information
S1 Fig. LC-MS/MS analysis in MRM mode of L-Asp, D-Asp and NMDA mixture. The TIC
chromatogram and the specific MRM transitions for each analyte are indicated.
(PPTX)
S1 Table. Experimental conditions for mouse brain sample treatment. Different extraction
and precipitation conditions were tested and the percentage (%) of recovery of the three ana-
lytes averaged for three experiments for each pair of conditions were calculated. Conditions
yielding the highest recovery for all three analytes were selected.
(PPTX)
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